Guidance and regulation

Information about ensuring blood and blood component safety.

• From: Medicines and Healthcare products Regulatory Agency
• Updated: 24 February 2021

What blood establishments, blood banks and manufacturers of blood products need to do to ensure the safety and quality of blood and blood products.

• From: Department of Health and Social Care
• Updated: 27 May 2021

Guidance for hospitals, tissue establishments and fertility clinics for ensuring the quality and safety of human organs, tissues and cells (including reproductive cells).

• From: Department of Health and Social Care
• Updated: 28 September 2021

Guidance for hospital blood banks on issuing blood components electronically in line with best practice.

• From: Medicines and Healthcare products Regulatory Agency
• Updated: 6 May 2010

Recommendations from the SaBTO occult hepatitis B infection (OBI) working group to introduce additional hepatitis B virus (HBV) testing.

• From: Department of Health and Social Care
• Updated: 6 April 2023

Updated recommendations from SaBTO's virology review subcommittee on seasonal influenza and the use of organs for donation.

• From: Department of Health and Social Care
• Updated: 23 October 2019

A mathematical model to estimate the number of cases of variant Creutzfeldt-Jakob Disease (vCJD) that could be caused by transfusions of blood products.

• From: Department of Health and Social Care
• Updated: 31 October 2019

Guidance to hospital blood banks (HBBs) on flexible approaches to requirements

• From: Medicines and Healthcare products Regulatory Agency
• Updated: 3 April 2020

Information on preventing and controlling the exposure of emergency service personnel to common blood-borne viruses.

• From: Closed organisation: Public Health England
• Updated: 4 October 2019